UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This piece evaluates performance in retirement for Sp 500 vs Multi Asset approaches, outlining where each may excel under different conditions.
26,383 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Tesla enters a pivotal period as AI-driven software and energy products meet traditional EV growth. This article asse...
Regional markets back demand remains resilient as rate pressure builds, with Texas leading loan activity and Californ...
NXT starts trading on four leading exchanges, fueling an on-chain AI entertainment ecosystem. The rollout highlights ...
SpaceX gears up for a public listing with a potential $75 billion raise and a multi-trillion-dollar valuation. Nasdaq...
Micron Technology surged as analysts raised their price targets on an AI-driven reset in memory markets. The stock mo...
Viral moments can ripple through a celebrity’s wallet and a fans' budget. This reality check translates into real mon...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...
QuantumScape and Honda announce a multi-year joint R&D pact to accelerate solid-state battery development, sending QS...
Apple reported a strong quarter with better-than-expected growth across iPhone and Services. Analysts say apple’s tar...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...
Institutional optimism around Ethereum is rising as new neutral stewardship groups launch and major firms signal inte...